Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis. by Prolong Pharma | Jul 1, 2020 | Publications
Targeting the HO-1/CO Pathway with Sanguinate: Toward Development of a Novel Anti-inflammatory Therapy for Cystic Fibrosis (CF) Lung Disease by Prolong Pharma | May 1, 2020 | Conferences
Resuscitation with PEGylated carboxyhemoglobin preserves renal cortical oxygenation and improves skeletal muscle microcirculatory flow during endotoxemia by Prolong Pharma | May 1, 2020 | Conferences
Microvascular and Systemic Impact of Resuscitation with PEGylated Carboxyhemoglobin-Based Oxygen Carrier or Hetastarch in a Rat Model of Transient Hemorrhagic Shock. by Prolong Pharma | Apr 1, 2020 | Publications
Artificial Blood: The History and Current Perspectives of Blood Substitutes by Prolong Pharma | Mar 1, 2020 | Publications
